KPIs & Operating Metrics(New)
Growth Metrics

Clover Health Investments (CLOV) Amortization - Deferred Charges (2020 - 2022)

Clover Health Investments' Amortization - Deferred Charges history spans 3 years, with the latest figure at $3000.0 for Q4 2022.

  • For Q4 2022, Amortization - Deferred Charges fell 66.67% year-over-year to $3000.0; the TTM value through Dec 2023 reached $3000.0, down 90.0%, while the annual FY2022 figure was $30000.0, 99.78% down from the prior year.
  • Amortization - Deferred Charges reached $3000.0 in Q4 2022 per CLOV's latest filing, down from $9000.0 in the prior quarter.
  • In the past five years, Amortization - Deferred Charges ranged from a high of $13.7 million in Q1 2021 to a low of $3000.0 in Q4 2022.
  • Average Amortization - Deferred Charges over 3 years is $2.7 million, with a median of $22000.0 recorded in 2021.
  • Peak YoY movement for Amortization - Deferred Charges: crashed 99.85% in 2021, then tumbled 30.77% in 2022.
  • A 3-year view of Amortization - Deferred Charges shows it stood at $6.2 million in 2020, then plummeted by 99.85% to $9000.0 in 2021, then crashed by 66.67% to $3000.0 in 2022.
  • Per Business Quant, the three most recent readings for CLOV's Amortization - Deferred Charges are $3000.0 (Q4 2022), $9000.0 (Q3 2022), and $18000.0 (Q2 2022).